Previous 10 | Next 10 |
Rite Aid Corporation (NYSE: RAD) today announced that it has issued a notice of redemption (the “Redemption”) for all $90,808,000 aggregate principal amount of its outstanding 6.125% Senior Notes Due 2023 (CUSIP No. 767754CH5 and CUSIP No. U76659AW8) (the “Notes...
No matter what industry we are talking about, #politics and policy changes can affect the #price of a #stock in that industry, and Rite Aid (NYSE: RAD) is not an exception. RAD like every other company, it will experience ebbs and flows based on this type of news too, so it is imp...
The vaccine is now a defining part of the world economy, with Evercore analysts predicting the first round of vaccinations (ie, those taking place this year before adjustments to new variants) will add up to about $140 billion in sales in the US. Stocks related to this theme make up a high in...
Image source: The Motley Fool. Rite Aid (NYSE: RAD) Q4 2021 Earnings Call Apr 15, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Rite Aid (RAD) Q4 2021 Earnings Call Transcript
Rite Aid Corporation (RAD) Q4 2021 Earnings Conference Call April 15, 2021, 08:30 AM ET Company Participants Trent Kruse - VP of IR and Treasury Heyward Donigan - CEO Jim Peters - COO Matt Schroeder - CFO Conference Call Participants George Hill - Deutsche Bank Glen Santangelo - Guggenheim Ke...
Rite Aid ([[RAD]] -6.9%) reports revenues growth of 3.3% in Q1.Retail Pharmacy revenue +3% to $4.11B and Pharmacy Services revenue +3.8% to $1.9B.Same store sales from continuing operations decreased 0.3% Y/Y vs. consensus of -0.2% and Front-end same store sales, decreased 5%, driven by ...
The following slide deck was published by Rite Aid Corporation in conjunction with their 2021 Q4 earnings call. For further details see: Rite Aid Corporation 2021 Q4 - Results - Earnings Call Presentation
Rite Aid (RAD): FQ4 Non-GAAP EPS of -$0.78 beats by $0.24; GAAP EPS of -$0.34 beats by $0.62.Revenue of $5.92B (+3.3% Y/Y) beats by $70M.Total revenues are projected to be between $6.1B-$6.3B in the Q1 with Retail Pharmacy Segment same store sales expected to range from a decrease of 9% to a ...
Fourth Quarter Net Loss from Continuing Operations of $18.5 Million or $0.34 Per Share, Compared to the Prior Year Fourth Quarter Net Loss of $343.5 Million or $6.43 Per Share Fourth Quarter Adjusted EBITDA from Continuing Operations of $41.3 Million, Compared to the Pri...
Rite Aid (NYSE:RAD) is scheduled to announce FQ4 earnings results on Thursday, April 15th, before market open.The consensus EPS Estimate is -$1.02 vs. -$0.37 and the consensus Revenue Estimate is $5.85B (+2.1% Y/Y).Analyst expects comps of (0.2%).Over the last 2 years, RAD has beate...
News, Short Squeeze, Breakout and More Instantly...
Secures Interim Approval to Access Up to $3.45 Billion in Debtor-in-Possession Financing Continues to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online Platforms Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Compan...
Stein Succeeds Elizabeth “Busy” Burr Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) an...
Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan Initiates Voluntary Chapter 11 Process to Implement a Consensual Financial Restructuring That Will Significantly Reduce Debt and Enable Execution of Key Initiatives Receives Commitment f...